Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
1.
Dig Liver Dis ; 32(3): 217-25, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10975772

ABSTRACT

BACKGROUND: We have shown that the administration of exogenous Augmenter of Liver Regeneration protein in intact rats i) regulates mitochondrial gene expression by inducing the transcription and translation of the nuclear-encoded mitochondrial transcription factor A, and ii) inhibits the lytic activity of liver-resident Natural Killer cells. AIMS: The present investigation was carried out to study the effect, in intact rats, of exogenous administration of Augmenter of Liver Regeneration protein on Interferon-gamma, a cytokine produced by activated Natural Killer cells and known to control the expression of mitochondrial transcription factor A, a nuclear gene responsible for mitochondrial metabolism. METHODS: Interferon-gamma was measured as messenger RNA in liver-derived mononuclear leukocytes and as protein in liver-derived Natural Killer cells after a single injection of Augmenter of Liver Regeneration protein. RESULTS: The data obtained demonstrate that: i) in intact rats, Augmenter of Liver Regeneration protein administration induces a reduction of Interferon-gamma in the liver-resident Natural Killer cells and ii) the administration of Interferon-gamma in 70% hepatectomized rats is followed by a significant reduction both of the mitochondrial transcription factor A expression and of liver regeneration. CONCLUSIONS: These data demonstrate the pivotal role of Augmenter of Liver Regeneration as Growth Factor and as immunoregulator by controlling, through Interferon-gamma levels, the mitochondrial transcription factor A expression and the lytic activity of liver-resident Natural Killer cells.


Subject(s)
Growth Substances/pharmacology , Hepatocytes/cytology , Interferon-gamma/metabolism , Liver Regeneration/immunology , Mitochondrial Proteins , Nuclear Proteins , Proteins , RNA, Messenger/genetics , Animals , Blotting, Western , Cell Division/drug effects , DNA Primers/chemistry , DNA-Binding Proteins/drug effects , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Flow Cytometry , Gene Expression/drug effects , Hepatocytes/drug effects , Interferon-gamma/genetics , Interferon-gamma/pharmacology , Killer Cells, Lymphokine-Activated/metabolism , Liver Regeneration/drug effects , Male , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , RNA, Messenger/metabolism , Rats , Rats, Inbred F344 , Reverse Transcriptase Polymerase Chain Reaction , Transcription Factors/drug effects , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription, Genetic/drug effects
2.
Gastrointest Endosc ; 51(6): 772, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10840330
4.
Hepatology ; 25(2): 411-5, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9021955

ABSTRACT

Fine balanced sequential changes of the levels of circulating hepatotrophic factors are essential for normal liver regeneration. Our recent studies have indicated that liver-resident natural killer (NK) cells are important regulators of liver regeneration and have raised the possibility that hepatotrophic factors might mediate their activities through NK cells. In the present study, we assessed the effects of in vivo administration of three hepatotrophic factors (augmenter of liver regeneration [ALR], insulin-like growth factor-II [IGF-II], and hepatocyte growth factor [HGF]) on NK cells in normal rats. Each of the three, given over a 1-day period in doses known to produce hepatotrophic activity, induced inhibition of NK cell cytotoxic activities in the population of mononuclear leukocytes (MNL) in the liver, but not in MNL from the spleen or peripheral blood. In contrast to these results obtained by the whole animal treatment, the three molecules had no effect on NK cell functions when added to cultures of MNL from the livers, spleens, or blood of untreated rats. These data support and extend our previously advanced hypothesis that ALR and other hepatotrophic factors play an important role in liver regeneration by regional regulation of NK cells through some as-yet-unknown intermediary mechanism.


Subject(s)
Growth Substances/pharmacology , Hepatocyte Growth Factor/pharmacology , Insulin-Like Growth Factor II/pharmacology , Killer Cells, Natural/drug effects , Proteins , Animals , Hepatectomy , Killer Cells, Natural/physiology , Male , Monocytes/drug effects , Monocytes/physiology , Rats , Rats, Inbred F344 , Specific Pathogen-Free Organisms
5.
J Immunol ; 154(12): 6324-38, 1995 Jun 15.
Article in English | MEDLINE | ID: mdl-7759871

ABSTRACT

To determine the role of NK cells in regulation of tissue growth, the phenotype and function of liver-resident NK cells were studied after 70% partial hepatectomy in rats. The process of liver regeneration was generally completed by day 14. In contrast, the number of liver-resident NK cells (NKR-P1bright) was restored as early as day 3 after partial hepatectomy. However, spontaneous functions of liver-resident NK cells, including killing of YAC-1 and P815 targets, Ab-dependent cellular cytotoxicity, and redirected killing via NKR-P1, were continuously suppressed throughout the entire period of liver regeneration (from 3 h to 14 days). Augmentation of NK cytotoxicity against P815 targets and induction of NK cell adherence to plastic following 24 h of IL-2 stimulation showed a similar pattern of suppression. However, IL-2-induced augmentation of YAC-1 killing, proliferation and generation of adherent NK cells, and LAK activity in 5- to 7-day cultures were found to be suppressed only during the first 24 h and increased between days 2 and 7 after hepatectomy. Sorted NK cells (> or = NKR-P1bright) from liver-resident mononuclear leukocytes 24 h after partial hepatectomy showed the same pattern of suppression as unsorted mononuclear leukocytes. In contrast to liver-resident NK cells, no significant changes were detected in peripheral blood or spleen NK cells of rats following partial hepatectomy. Of particular interest, in normal liver, hepatocytes were resistant to NK lysis, while resident NK cells were cytotoxic for various NK-sensitive targets. In contrast, during the early period of liver regeneration, when hepatocytes were sensitive to lysis by liver-resident NK cells of normal rats, NK cells obtained from regenerating liver tissues were unable to mediate cytotoxicity. At the final phase of liver regeneration (days 7-14 after hepatectomy), both resistance of hepatocytes to killing by NK cells and cytotoxicity of liver-resident lymphocytes against hepatocytes from regenerating liver were simultaneously restored. In vivo depletion of NK cells by injection of rats with anti-NKR-P1 mAb resulted in a significant augmentation of liver regeneration subsequent to partial hepatectomy. Our data suggest that liver-resident NK cells may be involved in regulation of the extent of liver regeneration.


Subject(s)
Killer Cells, Natural/immunology , Liver Regeneration/immunology , Liver/immunology , Animals , Antibodies, Monoclonal , Cytotoxicity, Immunologic , Hepatectomy , Immune Tolerance , Liver/cytology , Lymphocyte Depletion , Male , Phenotype , Rats , Rats, Inbred F344 , T-Lymphocytes/immunology , Time Factors
6.
Hepatology ; 21(4): 1070-8, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7705781

ABSTRACT

The proliferative response of the rat liver was measured after temporary or permanent total biliary obstruction (BDO) and in different regions after selective ligation of the lobar ducts draining the right 60% of the hepatic mass. The results were compared with those after 70% partial hepatectomy (PH). Cell proliferation was assessed globally by measuring DNA synthesis and stratified to the separate cell populations with cytostaining techniques that allowed distinction of hepatocytes, duct cells, and nonparenchymal cells (NPCs). In selected experimental groups, gene expression was determined of transforming growth factor-beta 1 (TGF beta-1), prothrombin, c-erb-B2, transforming growth factor alpha (TGF alpha), human Cyclophilin (CyP), and 28S ribosomal RNA. The stimulation of a proliferative response to total BDO required obstruction for longer than 24 hours, but after this deligation did not switch off regeneration. In the first week after permanent BDO, there was progressive infiltration of NPCs, fibrous linkage of some portal areas, and a crescendo of DNA synthesis that was obvious at 24 hours, maximal at 48 hours, and back nearly to baseline at 6 days. At the 2-day mark, the bile duct cells had a 17-fold increase in proliferation, accompanied by a threefold to fourfold increase in hepatocyte renewal. Little or no increase in expression of TGF alpha or the hepatocyte-specific prothrombin gene was detectable in the first 48 hours, whereas levels of the oncogene c-erb-B2 that is associated with cholangiocarcinoma were expressed from 48 to 96 hours.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Bile Ducts/pathology , Cholestasis/pathology , Gene Expression Regulation , Proto-Oncogenes , Animals , Bromodeoxyuridine/metabolism , Cell Division , Cholestasis/metabolism , DNA/biosynthesis , Hepatectomy , Male , Rats , Rats, Inbred F344 , Receptor, ErbB-2/genetics , Transforming Growth Factor beta/genetics
7.
Hepatology ; 20(5): 1237-41, 1994 Nov.
Article in English | MEDLINE | ID: mdl-7927257

ABSTRACT

Subcutaneous injections of hormone triiodothyronine in rats resulted in peak blood levels at 24 hr with return to baseline by 96 hr. The injections stimulated a liver regeneration response that resembled in timing and in magnitude of DNA synthesis (peak, 24 hr) that induced by 40% hepatic resection. The principal proliferation was of hepatocytes. Although there were some temporal differences from the gene expression of transforming growth factor-alpha, transforming growth factor-beta, and c-Ha-ras that are known to follow partial hepatectomy, the overall profile of these changes was similar to those after partial resection. The effect was liver specific and could be reproduced three times with no diminution in response in the same animal with injections at 10-day intervals. No response was detected in kidney or intestine. This effect in intact animals contrasted with the minimal ability of triiodothyronine to stimulate hepatocytes in culture. However, when the culture medium was enriched with epidermal growth factor, there was a dose-related response to triiodothyronine. The totality of these experiments provides a preliminary basis for the creation with pharmacological techniques of an in vivo hyperplastic hepatic condition permissive of transfection of new genes, as an alternative to partial hepatectomy. Although triiodothyronine was the test agent used, other hepatic growth factors singly or in combination could be candidates for this purpose.


Subject(s)
Gene Expression/drug effects , Liver/cytology , Triiodothyronine/pharmacology , Animals , Cell Division/drug effects , DNA/biosynthesis , Genes, ras , Male , Rats , Rats, Inbred F344 , Transforming Growth Factor alpha/genetics , Transforming Growth Factor beta/genetics
8.
Transplantation ; 58(4): 408-14, 1994 Aug 27.
Article in English | MEDLINE | ID: mdl-8073508

ABSTRACT

Rat livers were preserved with the conventional use of UW solution for 30, 42, and 48 hr and compared with livers in which the vascular bed was expanded with an additional 10 to 60 ml UW/100 g liver. The extra UW, expressed as % liver weight, was entrapped during final portal infusion by typing off the supra- and infrahepatic inferior vena cava. A beneficial influence of the vascular expansion was most pronounced in the 40% group, with 10/10, 5/10, and 3/10 long-term survivors following transplantation after 30, 42, and 48 hr preservation versus 3/10 and 0/10 after 30 and 42 hr in the 0% controls. In separate experiments, surrogate indices of preservation quality following reperfusion explained this effect. The 40%--and, to a lesser extent, 20%--livers had higher and more uniformly distributed portal blood flow, better tissue oxygenation, smaller increases in postperfusion liver enzymes, higher adenine nucleotides and energy charge, and less histopathologic evidence of hemorrhage and congestion. Pressure changes in the vena cava fluid sump in additional experiments indicated that retrograde infusion of the trapped UW solution occurred in all of the 10-60% groups during the first 6 hr with stable pressures of 1.5 to 3 cm H2O thereafter. Collectively, these data suggest that the much discussed selective vulnerability of the microvasculature of stored allografts is due in part (or principally) to its selective lack of long-term exposure to the UW solution, which drains out of the open vessels but not from the parenchyma. The potential clinical exploitation of this concept is discussed.


Subject(s)
Cryopreservation/methods , Liver Transplantation/physiology , Organ Preservation Solutions , Tissue Preservation , Adenosine , Allopurinol , Animals , Glutathione , Graft Survival/physiology , Infusions, Intravenous , Insulin , Liver Circulation/physiology , Liver Function Tests , Male , Oxygen Consumption , Portal Vein/physiology , Raffinose , Rats , Rats, Inbred Lew
10.
Pharmacol Toxicol ; 72(4-5): 296-9, 1993.
Article in English | MEDLINE | ID: mdl-8372050

ABSTRACT

In this study the effect of epomediol (1,3,3-trimethyl-2-oxabicyclo 2.2.2 ocatan-6,7-endo, endo-diol) (Clesidren) on rat hepatocyte bile acid transport was evaluated using [3H]-taurocholate as a probe, in order to clarify the mechanism of action of this drug. To this purpose, primary cultures were prepared with hepatocytes obtained from normal rats (Group I), and rats receiving a 4-day treatment with either epomediol (100 mg/kg) (Group II), or ethinyloestradiol (5 mg/kg) (Group III), or ethinyloestradiol plus epomediol (5 mg and 100 mg/kg respectively) (Group IV) or vehicle DMSO 50 microliters/kg) (Group V). All hepatocytes were isolated 10 days after the end of treatment. Hepatocyte [3H]-taurocholate uptake was evaluated in vitro after 48 hr of incubation in the presence or absence of epomediol. In both cases no difference was found when evaluating the uptake of hepatocytes from Group I, II and V. In the absence of epomediol [3H]-taurocholate uptake in hepatocytes from rats of Group IV was significantly higher than that observed in hepatocytes from rats of Group III. On the other hand, the presence of epomediol did not influence [3H]-taurocholate uptake in hepatocytes from rats of Group III, which remained significantly lower compared to that of control hepatocytes (Group V). The protective effect obtained when administering epomediol simultaneously with ethinyloestradiol (Group IV) was not due to its ability to compete with ethynyloestradiol for the binding to oestrogen receptors. Our results indicate that epomediol is able to restore a normal hepatocyte bile acid uptake when given in vivo simultaneously with ethinyloestradiol but does not influence bile acid transport in cultured hepatocytes. Further studies are required to better define the choleretic activity of this drug.


Subject(s)
Cholagogues and Choleretics/pharmacology , Cholestasis/metabolism , Liver/metabolism , Taurocholic Acid/metabolism , Terpenes/pharmacology , Animals , Bile Acids and Salts/metabolism , Bridged Bicyclo Compounds, Heterocyclic , Cells, Cultured , Cholestasis/chemically induced , Ethinyl Estradiol , Female , Liver/drug effects , Male , Rats , Rats, Inbred F344 , Receptors, Estrogen/metabolism , Terpenes/metabolism
11.
Hepatology ; 17(3): 429-33, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8444417

ABSTRACT

Sixty-two beagle dogs were given three doses of acetaminophen over a period of 24 hr in a fulminant liver failure model that is 70% lethal in 72 hr. Treatment of the animals with hepatic stimulatory substance alone or in a mixture with insulin, transforming growth factor-alpha and insulin-like growth factor II had no effect on mortality. Evidence of maximum regeneration with a mitotic index 20 to 25 times resting was the same in treated and untreated animals. Similarly, the biochemical and hematological indexes of liver injury were unaffected by therapy. These studies illustrate the futility of treating fulminant liver failure with exogenous growth factors that apparently are already present in large amounts in the natural response to liver injury. The results suggest that on-going liver injury by mechanisms other than lack of growth factors is the central problem of fulminant liver failure. If so, provision of regeneration-stimulating substance is an inappropriate therapeutic strategy.


Subject(s)
Acetaminophen , Growth Substances/pharmacology , Liver Failure/chemically induced , Liver Failure/pathology , Peptides/pharmacology , Animals , Cell Division , Dogs , Intercellular Signaling Peptides and Proteins , Liver Failure/mortality , Mitogens/pharmacology , Survival Analysis
17.
Hepatology ; 16(5): 1267-70, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1427665

ABSTRACT

Transforming growth factor-beta canceled the hepatocyte proliferation caused by transforming growth factor-alpha when the two substances were mixed and administered through a disconnected central portal vein branch after creation of an Eck fistula. In contrast, transforming growth factor-beta had no antidotal action on the stimulatory effects of insulin or full test doses of insulinlike factor-2, hepatocyte growth factor, epidermal growth factor or triiodothymanine. A minor antidotal effect on hepatic stimulatory substance activity could be detected, but only with hepatic stimulatory substance was given in doses smaller than those known to cause maximum stimulatory response. These results suggest a highly specific pharmacological and physiological interaction between transforming growth factor-alpha and transforming growth factor-beta in the modulation of liver growth control.


Subject(s)
Growth Substances/pharmacology , Liver/cytology , Portacaval Shunt, Surgical , Transforming Growth Factor beta/pharmacology , Animals , Cell Division , Dogs , Drug Interactions , Epidermal Growth Factor/pharmacology , Hepatocyte Growth Factor/pharmacology , Insulin/pharmacology , Insulin-Like Growth Factor II/pharmacology , Transforming Growth Factor alpha/pharmacology , Triiodothyronine/pharmacology
20.
Hepatology ; 15(5): 871-7, 1992 May.
Article in English | MEDLINE | ID: mdl-1568729

ABSTRACT

Rapamycin, a potent immunosuppressive drug that disrupts normal signal-transduction processes, inhibited hepatocyte proliferation without evidence of inherent cytotoxicity in rat hepatocytes cultured in conventional medium or in a medium enriched with epidermal growth factor. The antiproliferative effect was dose dependent, uninfluenced by the concentration of epidermal growth factor in the medium and long lasting after a brief exposure. The effect of rapamycin was unaltered by the concomitant presence of FK 506 in the medium, suggesting that different binding affinities of these two drugs or even a separate rapamycin binding site may exist. Hepatocytes harvested 12 and 24 hr after partial hepatectomy were progressively less responsive to the antiproliferative effect of rapamycin. The gene expression of transforming growth factor-beta was reduced under in vivo rapamycin treatment, but at the same time the gene expression of albumin and glyceraldehyde-3-phosphate dehydrogenase was unchanged or increased. The experiments confirm that rapamycin has inherent growth-control qualities, and they strengthen the hypothesis that the recently defined immunophilin network is central to many aspects of cellular growth control.


Subject(s)
Cell Division/drug effects , Gene Expression/drug effects , Immunosuppressive Agents/pharmacology , Liver/cytology , Polyenes/pharmacology , Animals , Cells, Cultured , Glyceraldehyde-3-Phosphate Dehydrogenases/biosynthesis , Liver Regeneration , Male , Rats , Rats, Inbred F344 , Sirolimus , Transforming Growth Factor beta/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...